Alkermes Makes Board Appointment
Alkermes plc., a global biopharma company focusing on the treatment of central nervous system diseases, has appointed Nancy Snyderman to its board of directors. Snyderman has more than 28 years of experience as a medical journalist, most recently at NBC News, where she was chief medical editor. Prior to her work in journalism, she was vice president of corporate communications at Johnson & Johnson. Snyderman is also a board certified otolaryngologist-head and neck surgeon, and a fellow of the American College of Surgeons.
Register for our free email digests: